Position in NTRA
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$3,489,489
-$192,326 QoQ
Shares Held
12,855
-30.2% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#303
of 844 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Eurizon Capital SGR S.p.A. holds $460,672,528 across 17 Diagnostics & Research names. NTRA ranks #10 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
539,965 | $270,716,852 | |
| 2 | DGX |
Quest Diagnostics Inc
|
222,564 | $47,172,439 | |
| 3 | DHR |
Danaher Corp /De/
|
243,409 | $46,364,546 | |
| 4 | A |
Agilent Technologies, Inc.
|
206,818 | $27,471,634 | |
| 5 | LH |
Labcorp Holdings Inc.
|
74,478 | $20,853,840 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
27,291 | $14,367,074 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
8,153 | $10,415,539 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
48,525 | $9,376,000 |
All Filings in NTRA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,489,489 | 12,855 | Shares | Other | 2026-07-29 | |
| 2026-03-31 | $3,681,815 | 18,410 | Shares | Other | 2026-05-08 | |
| 2025-12-31 | $3,312,412 | 14,459 | Shares | Other | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||